Related references
Note: Only part of the references are listed.Hyperaldosteronism as a Common Cause of Resistant Hypertension
David A. Calhoun
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Renal Sympathetic Denervation for Treatment of Resistant Hypertension: A Systematic Review
Priyanka Gosain et al.
JOURNAL OF CLINICAL HYPERTENSION (2013)
Resistant Hypertension Incidence, Prevalence, and Prognosis
Eduardo Pimenta et al.
CIRCULATION (2012)
Gender-Related Association of AGT Gene Variants (M235T and T174M) with Essential Hypertension-A Case-Control Study
Mohana U. Vamsi et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2012)
Lack of association of A-6G polymorphism of AGT gene with essential hypertension in the Chinese population
Yan-yan Li
JOURNAL OF CARDIOVASCULAR MEDICINE (2012)
Association of polymorphisms in the AGT gene with essential hypertension in the Chinese population
Bo Xi et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2012)
Association between the M235T polymorphism of the AGT gene and cytokines in patients with hypertension
Jing-Lin Cheng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008
Brent M. Egan et al.
CIRCULATION (2011)
Strategic Approaches to Unraveling Genetic Causes of Cardiovascular Diseases
A. J. Marian et al.
CIRCULATION RESEARCH (2011)
Gene Variation in Resistant Hypertension: Multilocus Analysis of the Angiotensin 1-Converting Enzyme, Angiotensinogen, and Endothelial Nitric Oxide Synthase Genes
Juan Carlos Yugar-Toledo et al.
DNA AND CELL BIOLOGY (2011)
Health Behaviors and Racial Disparity in Blood Pressure Control in the National Health and Nutrition Examination Survey
Nicole Redmond et al.
HYPERTENSION (2011)
Prevalence of Resistant Hypertension in the United States, 2003-2008
Stephen D. Persell
HYPERTENSION (2011)
Pharmacogenetic Effect of the Stromelysin (MMP3) Polymorphism on Stroke Risk in Relation to Antihypertensive Treatment The Genetics of Hypertension Associated Treatment Study
Richard Sherva et al.
STROKE (2011)
Matrix Metalloproteinases: Discrete Elevations in Essential Hypertension and Hypertensive End-Stage Renal Disease
Ryan S. Friese et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2009)
TNF-α regulates vascular smooth muscle cell responses in genetic hypertension
Se-Jung Lee et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap
Andrew D. Johnson et al.
BIOINFORMATICS (2008)
Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research
David A. Calhoun et al.
HYPERTENSION (2008)
Mechanisms and Treatment of Resistant Hypertension
Eduardo Pimenta et al.
JOURNAL OF CLINICAL HYPERTENSION (2008)
Interactions between metallopeptidase 3 polymorphism rs679620 and BMI in predicting blood pressure in African-American women with hypertension
Jacquelyn Taylor et al.
JOURNAL OF HYPERTENSION (2008)
The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) Heart Failure Validation Study: Diagnosis and prognosis
Paula T. Einhorn et al.
AMERICAN HEART JOURNAL (2007)
Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome
S Ye
CARDIOVASCULAR RESEARCH (2006)
Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension
LE Bautista et al.
JOURNAL OF HUMAN HYPERTENSION (2005)
Association between the CYP3A5 genotype and blood pressure
H Ho et al.
HYPERTENSION (2005)
Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension
T Hannila-Handelberg et al.
BMC MEDICAL GENETICS (2005)
Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease
AA Sethi et al.
HYPERTENSION (2003)
Validation of heart failure events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants assigned to doxazosin and chlorthalidone
LB Piller et al.
CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE (2002)
Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension:: The PROCAGENE study
JC Rodríguez-Pérez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Share Paper
